Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. The company has one segment being the research, development and commercialisation of health technologies.
| Last: | $0.001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.001 |
| Close: | $0.001 |
| High: | $0.001 |
| Low: | $0.001 |
| Volume: | 30,000 |
| Last Trade Date Time: | 09/06/2024 03:00:00 am |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Chimeric Therapeutics Ltd Ord Fully Paid (OTCMKTS: CHMMF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
